Full text
PDFPage 316
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Balch C. M., Soong S. J., Bartolucci A. A., Urist M. M., Karakousis C. P., Smith T. J., Temple W. J., Ross M. I., Jewell W. R., Mihm M. C. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996 Sep;224(3):255–266. doi: 10.1097/00000658-199609000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kirkwood J. M., Strawderman M. H., Ernstoff M. S., Smith T. J., Borden E. C., Blum R. H. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol. 1996 Jan;14(1):7–17. doi: 10.1200/JCO.1996.14.1.7. [DOI] [PubMed] [Google Scholar]
- Reintgen D., Balch C. M., Kirkwood J., Ross M. Recent advances in the care of the patient with malignant melanoma. Ann Surg. 1997 Jan;225(1):1–14. doi: 10.1097/00000658-199701000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]